Literature DB >> 12481944

Calcitonin: the other thyroid hormone.

Angela M Inzerillo1, Mone Zaidi, Christopher L H Huang.   

Abstract

Calcitonin was originally discovered as a hypocalcemic factor synthesized by thyroid parafollicular C cells. Early experiments demonstrated that calcitonin inhibited bone resorption and decreased calcium efflux from isolated cat tibiae and subsequent histologic and culture studies confirmed the osteoclast as its major site of action. Its potent antiresorptive effect and analgesic action have led to its clinical use in treatment of Paget's bone disease, osteoporosis, and hypercalcemia of malignancy. This review surveys the cellular and molecular basis of these physiologic and clinical actions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12481944     DOI: 10.1089/105072502760339352

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  4 in total

Review 1.  Mechanical, hormonal and metabolic influences on blood vessels, blood flow and bone.

Authors:  Rhonda D Prisby
Journal:  J Endocrinol       Date:  2017-08-16       Impact factor: 4.286

2.  Hormone-stimulated modulation of endocytic trafficking in osteoclasts.

Authors:  Gudrun Stenbeck; Kevin M Lawrence; Anthony P Albert
Journal:  Front Endocrinol (Lausanne)       Date:  2012-08-22       Impact factor: 5.555

3.  Calcitonin gene-related peptide and thermal injury: review of literature.

Authors:  Giulio Gherardini; Giuseppe Curinga; Giuseppe Colella; Nicola Freda; Raffaele Rauso
Journal:  Eplasty       Date:  2009-07-28

4.  Characterisation of CART-containing neurons and cells in the porcine pancreas, gastro-intestinal tract, adrenal and thyroid glands.

Authors:  Nils Wierup; Anna Gunnarsdóttir; Eva Ekblad; Frank Sundler
Journal:  BMC Neurosci       Date:  2007-07-11       Impact factor: 3.288

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.